We have previously reported the synthesis and the pharmacological characterization of a family of methyl 2-(acylamino)thiophene-3-carboxylates as GABAB positive allosteric modulators active both in vitro and in vivo. In the present work, we describe the synthesis of new compounds based on the bioisosteric replacement of the ester moiety with amido or heterocyclic groups as well as of thieno[2,3-d]pyrimidine derivatives as rigid analogues thereof. 4H-Thieno[2,3-d][1,3]oxazin-4-ones were used as synthetic intermediates for the preparation of some of these compounds. The structures of oxazinones 11b, 16, and 17 were assigned by X-ray crystallographic studies, which definitely ruled out the isomeric beta-lactam structure previously hypothesized for these compounds. None of the new molecules exhibited significant activity at the GABAB receptor, either as allosteric or orthosteric ligands.

Mugnaini, C., Pedani, V., Giunta, D., Sechi, B., Solinas, M., Casti, A., et al. (2014). Synthesis, 1 structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof. RSC ADVANCES, 4, 1782-1793 [10.1039/C3RA45546G].

Synthesis, 1 structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof

MUGNAINI, CLAUDIA;PEDANI, VALENTINA;GIORGI, GIANLUCA;CORELLI, FEDERICO
2014

Abstract

We have previously reported the synthesis and the pharmacological characterization of a family of methyl 2-(acylamino)thiophene-3-carboxylates as GABAB positive allosteric modulators active both in vitro and in vivo. In the present work, we describe the synthesis of new compounds based on the bioisosteric replacement of the ester moiety with amido or heterocyclic groups as well as of thieno[2,3-d]pyrimidine derivatives as rigid analogues thereof. 4H-Thieno[2,3-d][1,3]oxazin-4-ones were used as synthetic intermediates for the preparation of some of these compounds. The structures of oxazinones 11b, 16, and 17 were assigned by X-ray crystallographic studies, which definitely ruled out the isomeric beta-lactam structure previously hypothesized for these compounds. None of the new molecules exhibited significant activity at the GABAB receptor, either as allosteric or orthosteric ligands.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/751441
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo